| Study |
Reference |
|
Andersen 2017 (control exposed to MMI/CMZ), 2017
|
Andersen Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study. Eur. J. Endocrinol. 2017; 177:369-378
|
|
Andersen 2017 (control unexposed, disease free), 2017
|
Andersen Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study. Eur. J. Endocrinol. 2017; 177:369-378
|
|
Andersen 2017 (control unexposed, sick), 2017
|
Andersen Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study. Eur. J. Endocrinol. 2017; 177:369-378
|
|
Andersen 2019 (control exposed to MMI/CMZ), 2019
|
Andersen Maternal thyroid function, use of antithyroid drugs in early pregnancy and birth defects. J. Clin. Endocrinol. Metab. 2019; :
|
|
Andersen 2019 (control unexposed, disease free), 2019
|
Andersen Maternal thyroid function, use of antithyroid drugs in early pregnancy and birth defects. J. Clin. Endocrinol. Metab. 2019; :
|
|
Banhidy, 2011
|
Banhidy Possible association between hyperthyroidism in pregnant women and obstructive congenital abnormalities of urinary tract in their offspring--a population-based case-control study. J. Matern. Fetal. Neonatal. Med. 2011; 24:305-12
|
|
Chen (Control exposed to MMI), 2011
|
Chen Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG 2011; 118:1365-73
|
|
Chen (control unexposed, disease free), 2011
|
Chen Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG 2011; 118:1365-73
|
|
Chen (control unexposed, sick), 2011
|
Chen Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG 2011; 118:1365-73
|
|
Clementi, 2010
|
Clementi Treatment of hyperthyroidism in pregnancy and birth defects. J. Clin. Endocrinol. Metab. 2010; 95:E337-41
|
|
Davis, 1989
|
Davis Thyrotoxicosis complicating pregnancy. Am. J. Obstet. Gynecol. 1989; 160:63-70
|
|
Gianetti (control exposed to MMI), 2015
|
Gianetti Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy. J. Endocrinol. Invest. 2015; 38:977-85
|
|
Gianetti (control unexposed, sick), 2015
|
Gianetti Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy. J. Endocrinol. Invest. 2015; 38:977-85
|
|
Hawken (control exposed to MMI), 2016
|
Hawken Management of Graves' disease during pregnancy in the Poitou-Charentes Region. Ann. Endocrinol. (Paris) 2016; 77:570-577
|
|
Howley, 2017
|
Howley Thyroid Medication Use and Birth Defects in the National Birth Defects Prevention Study. Birth Defects Res 2017; 109:1471-1481
|
|
Korelitz (control exposed to MMI), 2013
|
Korelitz Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid 2013; 23:758-65
|
|
Korelitz (control exposed to MMI), 2013
|
Korelitz Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid 2013; 23:758-65
|
|
Korelitz (control unexposed, disease free), 2013
|
Korelitz Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid 2013; 23:758-65
|
|
Korelitz (control unexposed, sick), 2013
|
Korelitz Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid 2013; 23:758-65
|
|
Lo (control exposed to MMI), 2015
|
Lo Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system. Thyroid 2015; 25:698-705
|
|
Lo (control unexposed, sick), 2015
|
Lo Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system. Thyroid 2015; 25:698-705
|
|
Momotani (control exposed to MMI), 1997
|
Momotani Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J. Clin. Endocrinol. Metab. 1997; 82:3633-6
|
|
Rosenfeld, 2009
|
Rosenfeld Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol 2009; 68:609-17
|
|
Seo (control exposed to MMI), 2018
|
Seo Antithyroid Drugs and Congenital Malformations: A Nationwide Korean Cohort Study. Ann. Intern. Med. 2018; 168:405-413
|
|
Seo (control unexposed, NOS), 2018
|
Seo Antithyroid Drugs and Congenital Malformations: A Nationwide Korean Cohort Study. Ann. Intern. Med. 2018; 168:405-413
|
|
Wing (control exposed to MMI), 1994
|
Wing A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am. J. Obstet. Gynecol. 1994; 170:90-5
|
|
Wing (control unexposed, sick), 1994
|
Wing A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am. J. Obstet. Gynecol. 1994; 170:90-5
|
|
Yoshihara (control exposed to MMI), 2012
|
Yoshihara Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J. Clin. Endocrinol. Metab. 2012; 97:2396-403
|
|
Yoshihara (control unexposed, sick), 2012
|
Yoshihara Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J. Clin. Endocrinol. Metab. 2012; 97:2396-403
|
|
Yoshihara (Controls exposed to MMI), 2021
|
Yoshihara Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution. J Endocr Soc 2021; 5:bvaa204
|
|
Yoshihara (Controls unexposed, sick), 2021
|
Yoshihara Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution. J Endocr Soc 2021; 5:bvaa204
|
|
Zhang, 2016
|
Zhang Follow-up and evaluation of the pregnancy outcome in women of reproductive age with Graves' disease after 131Iodine treatment. J. Radiat. Res. 2016; 57:702-708
|
